🇺🇸 FDA
Pipeline program

Vonsetamig

R5459-1979-LN-2459

Phase 1 small_molecule active

Quick answer

Vonsetamig for Lupus Nephritis (LN) is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Lupus Nephritis (LN)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials